Vanberra Signal

PredictImmune

Curated by Signal

Developer of tools for diagnosing immune-mediated inflammatory diseases

Overview

Developer of tools for diagnosing immune-mediated inflammatory diseases. The company is developing a pioneering suite of prognostic tools to guide treatment choice and improve patient outcomes in immune-mediated diseases. The company's first product, PredictSURE IBD stratifies patients with IBD (both Crohn’s disease and ulcerative colitis).

Key facts

Founded
2017

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of mobile app for tracking and managing thyroid health

    Health TechnologyBorehamwood, United Kingdom
  • Mobile-based app for the users to identify and monitor triggers related to allergies & asthma

    Health TechnologyLambeth, United Kingdom
  • Mobile-based app for fitness training and nutrition planning

    Health TechnologyLondon, United Kingdom

About PredictImmune

What does PredictImmune do?

Developer of tools for diagnosing immune-mediated inflammatory diseases.

Where is PredictImmune headquartered?

PredictImmune is headquartered in Cambridge, United Kingdom.

When was PredictImmune founded?

PredictImmune was founded in 2017.

Which sector is PredictImmune in?

PredictImmune operates in Health Technology.

Who are PredictImmune's competitors?

Companies similar to PredictImmune include PILIPALA, Digital Health Passport, and THRST.